Showing results (171-180 of 188) with videos related to

Sort By:
Pageof 19
Bone Marrow Transplantation|January 17, 2018
The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Bone Marrow Transplantation|September 21, 2018
Correction: The European Society for Blood and Marrow Transplantation (EBMT) Consensus Guidelines for the Detection and Treatment of Donor-specific Anti-HLA Antibodies (DSA) in Haploidentical Hematopoietic Cell TransplantationStefan O Ciurea, Kai Cao, Marcelo Fernandez-Vina, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 8, 2012
Evaluation of the practice of antifungal prophylaxis use in patients with newly diagnosed acute myeloid leukemia: results from the SEIFEM 2010-B registryLivio Pagano, Morena Caira, Anna Candoni, et al.
Blood|May 25, 2006
Immunohistochemistry predicts nucleophosmin (NPM) mutations in acute myeloid leukemiaBrunangelo Falini, Maria Paola Martelli, Niccolò Bolli, et al.
Infection and Immunity|March 30, 2021
Pharyngeal Microbial Signatures Are Predictive of the Risk of Fungal Pneumonia in Hematologic PatientsClaudio Costantini, Emilia Nunzi, Angelica Spolzino, et al.
Haematologica|October 24, 2009
Invasive aspergillosis in patients with acute myeloid leukemia: a SEIFEM-2008 registry studyLivio Pagano, Morena Caira, Anna Candoni, et al.
Cell Death & Disease|June 17, 2022
Identification of an Epi-metabolic dependency on EHMT2/G9a in T-cell acute lymphoblastic leukemiaAnna Montanaro, Samuel Kitara, Elisa Cerretani, et al.
Annals of Hematology|February 8, 2018
Febrile events in acute lymphoblastic leukemia: a prospective observational multicentric SEIFEM study (SEIFEM-2012/B ALL)Roberta Di Blasi, Chiara Cattaneo, Russell E Lewis, et al.
Cell Chemical Biology|May 11, 2020
Blockade of Oncogenic NOTCH1 with the SERCA Inhibitor CAD204520 in T Cell Acute Lymphoblastic LeukemiaMatteo Marchesini, Andrea Gherli, Anna Montanaro, et al.
Hematological Oncology|April 7, 2018
Epidemiology, outcome, and risk factors for infectious complications in myelofibrosis patients receiving ruxolitinib: A multicenter study on 446 patientsNicola Polverelli, Giuseppe A Palumbo, Gianni Binotto, et al.
Pageof 19